Raman Bhakhri, OD, FAAO, details a session given with Denise Skiadopoulos, OD, FAAO, during the annual AAOpt meeting in Anaheim, California.
|Videos|March 11, 2022
Significance of imaging in retinal disease scans
Mohammad Rafieetary, OD, FAAO, shares highlights from his SECO 2022 presentation titled "Image-in that! Scanning for retinal disease."
Advertisement
Mohammad Rafieetary, OD, FAAO, consultative optometric physician at the Charles Retina Institute in Germantown, Tennessee, speaks with Optometry Times®' Alex Delaney-Gesing on highlights from his SECO 2022 presentation titled "Image-in that! Scanning for retinal disease," including why optometrists should be knowledgeable about their diagnoistic devices.
Advertisement
Related to this article
Sherrol Reynolds, OD, FAAO, details her session "GLP-1RAs and Ocular Health: AOA Guidance for Optometric Practice 2025" during AAOpt 2026.
Three residents were honored for their leadership, education and research, and patient care contributions in ophthalmology, optometry, and retina.
Magdalena Stec, OD, FAAO, and Noreen Shaikh, OD, MEd, FAAO, gave an overview of current evidence-based myopia control treatments in part of their AAOpt 2026 session.
A pair of cases from Academy 2026 show scleral lens refits for severe keratoconus, one addressing focal corneal edema and one fitting around glaucoma tube shunts.
Nora Lee Cothran, OD, FAAO, reviews a study which found a statistically significant reduction in IOP in patients with open-angle glaucoma and ocular hypertension when switching to latanoprostene bunod.
Jade Coats, OD, FAAO, stopped by to discuss her presentation at AAOpt 2026, titled"How Eyelid Hygiene Can Change the Dry Eye Conversation."
Dry eye questionnaires capture only 22.4% of Demodex blepharitis symptoms, and a 22-study review links Demodex infestation to worse meibomian gland function.
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
AAOpt 2026: Demodex tied to worse MGD as dry eye questionnaires miss blepharitis
2
AAOpt 2026: Aflibercept 8 mg extends RVO dosing as Amsler misses AMD damage
3
AAOpt 2026: The real-world impact of treatment switch to latanoprostene bunod
4
AAOpt 2026: Patient-reported blurred vision improvement with Vevye
5